Trident II Tritanium Acetabular Shell Outcomes Study
Public ClinicalTrials.gov record NCT02999009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Post-market, Multi-center Study of the Trident II Tritanium Acetabular Shell
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.
Study identification
- NCT ID
- NCT02999009
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 383 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 19, 2017
- Primary completion
- Jun 9, 2026
- Completion
- Feb 28, 2031
- Last update posted
- Jun 28, 2026
2017 – 2031
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tucson Orthopaedic Institute | Tucson | Arizona | 85712 | — |
| Southeast Orthopedic Specialists | Jacksonville | Florida | 32204 | — |
| American Hip Institute | Des Plaines | Illinois | 60018 | — |
| Center for Orthopaedics and Spine, LLC | Lake Charles | Louisiana | 70605 | — |
| St. Joseph Mercy Hospital Health System | Ypsilanti | Michigan | 48197 | — |
| Rothman Institute | Egg Harbor | New Jersey | 08234 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| Northwell Health, Lenox Hill Hospital | New York | New York | 10075 | — |
| UNC Orthopaedics | Chapel Hill | North Carolina | 27599 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02999009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02999009 live on ClinicalTrials.gov.